Clinical Trial Update: A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating MASCT-I for safety and efficacy in patients with advanced solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• MASCT-I

Snippet

Sponsor: HRYZ Biotech Co. | Conditions: Advanced Solid Tumors | Phase 1 | Status: TERMINATED